Prostaglandin production by human gingival fibroblasts inhibited by triclosan in the presence of cetylpyridinium chloride

Journal of Periodontology

Volumn 76, Issue 10, 2005, Pages 1735-1742

  Kim, Young Joon ^a   Rossa Jr , Carlos ^b,c   Kirkwood, Keith L ^c  

^a Chonnam National University   (South Korea)

^b SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^c UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Cetylpyridinium chloride; COX 2; Fibroblasts; PGE2; Triclosan

Indexed keywords

CETYLPYRIDINIUM SALT; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38; PROSTAGLANDIN E2; TRICLOSAN; TUMOR NECROSIS FACTOR ALPHA;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL STIMULATION; CONTROLLED STUDY; CYTOTOXICITY; DOSE RESPONSE; DRUG EFFICACY; DRUG POTENTIATION; DRUG SELECTIVITY; FIBROBLAST CULTURE; GENE CONTROL; GENE EXPRESSION; GINGIVA; HUMAN; HUMAN CELL; MOUTH INFLAMMATION; NUCLEOTIDE SEQUENCE; PROSTAGLANDIN SYNTHESIS INHIBITION; SIGNAL TRANSDUCTION;

ANTI-INFECTIVE AGENTS, LOCAL; BLOTTING, WESTERN; CELLS, CULTURED; CETYLPYRIDINIUM; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; DINOPROSTONE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG COMBINATIONS; FIBROBLASTS; GENE EXPRESSION; GINGIVA; HUMANS; NF-KAPPA B; PROSTAGLANDIN ANTAGONISTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TRICLOSAN;

EID: 27844600088     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2005.76.10.1735     Document Type: Article

References (31)

1. Birkedal-Hansen H. Role of matrix metalloproteinases in human periodontal diseases. J Periodontol 1993; 64:474-484.
2. Miossec P. Cytokines in rheumatoid arthritis: Is it all TNF-alpha? Cell Mol Biol (Noisy-le-grand) 2001; 47:675-678.
3. Greenfield EM, Bi Y, Miyauchi A. Regulation of osteoclast activity. Life Sci 1999;65:1087-1102.
4. Gravallese EM, Galson DL, Goldring SR, Auron PE. The role of TNF-receptor family members and other TRAF-dependent receptors in bone resorption. Arthritis Res 2001;3:6-12.
5. Wilson M. Biological activities of lipopolysaccharides from oral bacteria and their relevance to the pathogenesis of chronic periodontitis. Sci Prog 1995;78: 19-34.
6. Koka S, Reinhardt RA. Periodontal pathogen-related stimulation indicates unique phenotype of primary cultured human fibroblasts from gingiva and periodontal ligament: Implications for oral health disease. J Prosthet Dent 1997;77:191-196.
7. Sjostrom S, Hanstrom L, Lerner UH. The bone resorbing activity released by gingival fibroblasts isolated from patients with periodontitis is independent of interleukin-1. J Periodontal Res 2000;35:74-84.
8. Offenbacher S, Collins JG, Heasman PA. Diagnostic potential of host response mediators. Adv Dent Res 1993;7:175-181.
9. Offenbacher S. Periodontal diseases: Pathogenesis. Ann Periodontol 1996;1:821-878.
10. Lasa M, Brook M, Saklatvala J, Clark AR. Dexamethasone destabilizes cyclooxygenase 2 mRNA by inhibiting mitogen-activated protein kinase p38. Mol Cell Biol 2001;21:771-780.
11. Hu D, Zhang J, Wan H, Zhang Y, Volpe AR, Petrone ME. Hua Xi Kou Qiang Yi Xue Za Zhi 1997;15:333-335.
12. Lindhe J, Rosling B, Socransky SS, Volpe AR. The effect of a triclosan-containing dentifrice on established plaque and gingivitis. J Clin Periodontol 1993; 20:327-334.
13. Barkvoll P, Rolla G. Triclosan protects the skin against dermatitis caused by sodium lauryl sulphate exposure. J Clin Periodontol 1994;21:717-719.
14. Kjaerheim V, Barkvoll P, Waaler SM, Rolla G. Triclosan inhibits histamine-induced inflammation in human skin. J Clin Periodontol 1995;22:423-426.
15. Modeer T, Bengtsson A, Rolla G. Triclosan reduces prostaglandin biosynthesis in human gingival fibroblasts challenged with interleukin-1 in vitro. J Clin Periodontol 1996;23:927-933.
16. Gaffar A, Scherl D, Afflitto J, Coleman EJ. The effect of triclosan on mediators of gingival inflammation. J Clin Periodontol 1995;22:480-484.
17. Nafee NA, Boraie MA, Ismail FA, Mortada LM. Design and characterization of mucoadhesive buccal patches containing cetylpyridinium chloride. Acta Pharm 2003; 53:199-212.
18. Natsume H, Iwata S, Ohtake K, et al. Screening of cationic compounds as an absorption enhancer for nasal drug delivery. Int J Pharm 1999;185:1-12.
19. Bradford PG, Maglich JM, Ponticelli AS, Kirkwood KL. The effect of bone morphogenetic protein-7 on the expression of type I inositol 1,4,5-trisphosphate receptor in G-292 osteosarcoma cells and primary osteoblast cultures. Arch Oral Biol 2000;45:159-166.
20. Kirkwood KL, Golub LM, Bradford PG. Non-antimicrobial and antimicrobial tetracyclines inhibit IL-6 expression in murine osteoblasts. Ann N Y Acad Sci 1999; 878:667-670.
21. Zuckerbraun HL, Babich H, May R, Sinensky MC. Triclosan: Cytotoxicity, mode of action, and induction of apoptosis in human gingival cells in vitro. Eur J Oral Sci 1998;106:628-636.
22. Babich H, Babich JP. Sodium lauryl sulfate and triclosan: In vitro cytotoxicity studies with gingival cells. Toxicol Lett 1997;91:189-196.
23. 2 production in human gingival fibroblasts stimulated with interleukin-1beta and epidermal growth factor. Biochem Biophys Res Commun 1999;257:528-532.
24. Molina-Holgado E, Ortiz S, Molina-Holgado F, Guaza C. Induction of COX-2 and PGE(2) biosynthesis by IL-1beta is mediated by PKC and mitogen-activated protein kinases in murine astrocytes. Br J Pharmacol 2000;131:152-159.
25. Ridley SH, Dean JL, Sarsfield SJ, Brook M, Clark AR, Saklatvala J. A p38 MAP kinase inhibitor regulates stability of interleukin-1-induced cyclooxygenase-2 mRNA. FEBS Lett 1998;439:75-80.
26. Bauer MK, Lieb K, Schulze-Osthoff K, et al. Expression and regulation of cyclooxygenase-2 in rat microglia. Eur J Biochem 1997;243:726-731.
27. Rothwarf DM, Karin M. The NF-kappa B activation pathway: A paradigm in information transfer from membrane to nucleus. Sci STKE 1999;1999:RE1.
28. Nakao S, Ogata Y, Shimizu-Sasaki E, Yamazaki M, Furuyama S, Sugiya H. Activation of NFkappaB is necessary for IL-1beta-induced cyclooxygenase-2 (COX-2) expression in human gingival fibroblasts. Mol Cell Biochem 2000;209:113-118.
29. 2 release is mediated by the activation of cyclooxygenase-2 (COX-2) transcription via NFkappaB in human gingival fibroblasts. Mol Cell Biochem 2002;238:11-18.
30. Mestre JR, Mackrell PJ, Rivadeneira DE, Stapleton PP, Tanabe T, Daly JM. Redundancy in the signaling pathways and promoter elements regulating cyclooxygenase-2 gene expression in endotoxin-treated macrophage/monocytic cells. J Biol Chem 2001;276: 3977-3982.
31. 2 secretion as a determinant of periodontal disease expression. J Periodontol 1993;64:432-444.